AIM stock forecast
Our latest prediction for AIM ImmunoTech Inc's stock price was made on the Feb. 24, 2021 when the stock price was at 2.60$.
In the short term (2weeks), AIM's stock price should outperform the market by 3.32%. During that period the price should oscillate between -11.16% and +18.43%.
In the medium term (3months), AIM's stock price should underperform the market by -3.59%. During that period the price should oscillate between -44.14% and +44.67%.Get email alerts
Create a solid portfolio with AIM
About AIM ImmunoTech Inc
AIM ImmunoTech Inc. is an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers, immune disorders, and viral diseases, including COVID-19, the disease caused by the SARS-CoV-2 virus.
At the moment the company doesn't generate any revenue.
On its last earning announcement, the company reported a profit of 1.43$ per share.
The book value per share is 1.17$
Three months stock forecastFeb. 24, 2021
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|